GeneDx Holdings Corp. (NASDAQ:WGS) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the GeneDx Third Quarter 2024 Earnings Conference Call.
Genedx Holdings Corp. (WGS)
Market is closed
Sector: Services-Health Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Casdin Capital Eli Casdin | 3,526,411 | $92,180,384 | +13% | 7.03% |
| 2. | Corvex Capital Keith Meister | 2,473,781 | $64,664,635 | 2.98% | |
| 3. | Driehaus Capital Richard Driehaus | 433,635 | $11,335,219 | 0.1% | |
| 4. | Millennium Management Israel Englander | 311,401 | $8,140,022 | +194% | 0% |
| 5. | Divisadero Street Capital William Zolezzi | 225,170 | $5,885,944 | 0.89% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.52 | 30,000 | Large Shareholder, Director | 3,093,509 | 2024-06-04 | Filing | |
| $20.82 | 100,000 | Large Shareholder, Director | 3,063,509 | 2024-06-03 | Filing | |
| $21.07 | 40,000 | Large Shareholder, Director | 2,963,509 | 2024-05-29 | Filing | |
| $20.61 | 18,304 | Large Shareholder, Director | 2,923,509 | 2024-05-28 | Filing | |
| $20.12 | 144,196 | Large Shareholder, Director | 2,905,205 | 2024-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.60 | 274 | 44,951 | 2024-10-29 | Filing | ||
| $66.60 | 2,154 | 105,426 | 2024-10-29 | Filing | ||
| $37.59 | 10,501 | 103,706 | 2024-09-16 | Filing | ||
| $37.59 | 2,635 | 44,472 | 2024-09-16 | Filing | ||
| $33.33 | 895 | 39,910 | 2024-09-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,686,831 | $4,638,785 | 0% | |
| 2. | 835,062 | $2,296,421 | 0.01% | |
| 3. | 784,128 | $2,156,355 | 0% | |
| 4. | 678,934 | $1,867,069 | 0% | |
| 5. | 349,278 | $960,515 | 0.23% |
News See All
GeneDx Holdings Corp. (NASDAQ:WGS) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the GeneDx Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2024 Earnings Call Transcript
GeneDx Holdings Corp. beats earnings expectations. Reported EPS is $-0.33, expectations were $-0.68. GeneDx Holdings Corp.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the GeneDx Fourth Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
GeneDx Holdings Corp. (NASDAQ:WGS) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
5 Best AI Penny Stocks to Buy Now
AI-based speech recognition company SoundHound AI, Inc. (NASDAQ:SOUN) shares have gained about 50% year to date through August 7. SoundHound AI, Inc.
GeneDx Holdings Corp. (NASDAQ:WGS) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the GeneDx Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Be advised that today's conference is being recorded.
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the GeneDx' First Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to GeneDx' Fourth Quarter 2022 Earnings Conference Call. I would now like to hand the call over to Head of Investor Relations, Tricia Truehart.
Billionaire Hedge Funds
